Chempass Company
ChemPass was founded to develop AI technologies and software for the design of novel small organic molecules and scaffolds. ChemPass' technologies utilize synthetic artificial intelligence for template design, in silico reaction planning and evaluation, a chemistry know-how database and several other custom solutions.
%20.jpg)
Funding Status:
Seed
Headquarters:
Budapest, Budapest, Hungary
Founded Date:
2016
Investor Type:
N/A
Investment Stage:
N/A
Technology:
Drug Design
Employee Number:
Undisclosed
Number Of Exists:
N/A
Industry:
Drug Discovery